AEON Biopharma, Inc. (AEON) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $5.56M | +77.0% |
| 2024 | $3.14M | -54.1% |
| 2023 | $6.84M | -36.5% |
| 2022 | $10.78M | -96.1% |
| 2021 | $276.95M | +341813.0% |
| 2020 | $81.0K | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $5.56M | +77.0% |
| 2024 | $3.14M | -54.1% |
| 2023 | $6.84M | -36.5% |
| 2022 | $10.78M | -96.1% |
| 2021 | $276.95M | +341813.0% |
| 2020 | $81.0K | — |